MedTrace Logo

ECMO for Critically Ill Patients With Respiratory Failure and/or Circulatory Failure

NCT04031794 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2022-09-21

No results posted yet for this study

Summary

Extracorporeal membrane oxygenation (ECMO) had been used to treat refractory hypoxemia associated with acute respiratory distress syndrome (ARDS). There were reported good outcome associated with ECMO for ARDS caused by influenza infection from several ECMO centers. However, the outcome of ECMO support in lower ECMO experience center had not been evaluated. This study aimed to evaluate the outcome of ECMO, comparing with conventional treatment among severe hypoxemic ARDS patients who were admitted in limited ECMO experience hospital.

Conditions

  • Severe Acute Respiratory Distress Syndrome
  • Refractory Hypoxemia

Interventions

DEVICE

Extra Corporeal Membrane Oxygenator (ECMO)

Two cannular will be inserted via femoral vein or internal jugular vein and connect with blood pump and membrane oxygenation.

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • Surat Tongyoo, Dr. · Mahidol University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-22
Primary Completion
2025-07-30
Completion
2025-07-31

Countries

  • Thailand

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04031794 on ClinicalTrials.gov